Global RNA Based Therapeutics Market 2024-2028
RNA Based Therapeutics Market 2024-2028
The RNA based therapeutics market is forecasted to grow by USD 1268.2 mn during 2023-2028, accelerating at a CAGR of 5.54% during the forecast period. The report on the RNA based therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing investment and funding in RNA based therapeutics, expansion of RNA based therapeutics through government authorization, and rising incidence of chronic and infectious diseases.
Technavio's RNA based therapeutics market is segmented as below:
By Type
- mRNA therapeutics
- Antisense oligonucleotide (ASO) therapeutics
- RNA interference (RNAi) therapeutics
- Others
By Route Of Administration
- Intravenous (IV)
- Subcutaneous (SC)
- Intramuscular (IM)
By Geographical Landscape
- Europe
- North America
- Asia
- Rest of World (ROW)
This study identifies the increasing collaborations and partnerships as one of the prime reasons driving the RNA based therapeutics market growth during the next few years. Also, developments in gene editing technologies and advancements in drug delivery systems will lead to sizable demand in the market.
The report on the RNA based therapeutics market covers the following areas:
- RNA based therapeutics market sizing
- RNA based therapeutics market forecast
- RNA based therapeutics market industry analysis
The vendors analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading RNA based therapeutics market vendors that include Alnylam Pharmaceuticals Inc., Arbutus Biopharma Corp., Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals Inc., Ascidian Therapeutics Inc, AstraZeneca PLC, Beam Therapeutics Inc., Benitec Biopharma Inc., Biogen Inc., BioNTech SE, BioSpace, Circular Genomics Inc., CureVac AG, Esperovax, Gennova Biopharmaceuticals Ltd, Ionis Pharmaceuticals Inc., Moderna Inc., Novartis AG, Novo Nordisk AS, Omega Therapeutics Inc., Sarepta Therapeutics Inc., Silence Therapeutics PLC, and Tevard Biosciences. Also, the RNA based therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.